Introduction
============

Gastroesophageal reflux disease (GERD) represents a common condition having a substantial impact on the patients' quality of life, as well as the health system. According to the Montreal definition and classification system, GERD develops when the reflux of stomach contents leads to troublesome symptomatology and/or complications.[@b1-jnm-25-436] Numerous typical symptoms appear in GERD, such as heartburn and acid regurgitation, some atypical ones, like dysphagia and chest pain. Extra-esophageal symptoms, such as chronic cough and laryngitis may also be present.[@b2-jnm-25-436]--[@b4-jnm-25-436] Esophageal exposure to gastric acid in patients with GERD can be severe enough to cause endoscopically visible mucosal damage (erosive esophagitis), esophagus stenosis, and Barrett's esophagus (BE). The latter may subsequently lead to esophageal adenocarcinoma (EAC). A considerable number of patients present no endoscopically visible damage to the esophageal mucosa, despite the symptoms of GERD and esophageal exposure to the acid. This condition has been referred to as non-erosive reflux disease (NERD).[@b5-jnm-25-436]

Various factors, such as cellular, molecular, and genetic factors, may affect the severity of GERD. Limited studies have shown that host genetic factors may affect the development of GERD, including genes that can modulate the gastric acid secretion (pre- and anti-inflammatory agents, and those involved in the acid secretion pathway), the DNA repair pathway (for BE and EAC), the carcinogenic pathway for removing toxins (for EAC), cell cycle regulator pathway, and visceral hypersensitivity during acid reflux in the esophagus.[@b6-jnm-25-436] The role of genetics in the pathogenesis of GERD, including BE and EAC, has been demonstrated by studies on monozygotic and dizygous twins (correlation for gastroesophageal reflux in monozygotic twins), the increased risk of disease in people with a positive family history, and the Genome-Wide Association Studies which recently identified single-nucleotide polymorphisms (SNPs) associated with GERD and its complications. According to many studies, the *BARX1* and *ADAMTS17* genes have been suggested as genetic risk loci for the development of GERD and its complications.[@b7-jnm-25-436]--[@b10-jnm-25-436]

The aim of the study is to evaluate whether *BARX1* and *AD-AMTS17* polymorphisms (rs11789015 and rs4965272, respectively) are associated with gastroesophageal acid reflux risk in our well-defined Greek population. Any negative or positive association of SNPs with GERD represents a new insight in the pathogenesis of the disease.

Materials and Methods
=====================

Study Population
----------------

Our study included 160 GERD patients and 180 sex- and age-matched healthy individuals, all of Greek origin. The patients were recruited at three hospitals, the 2nd Department of Surgery and Gastroenterology unit, School of Medicine, University of Athens; the Department of Gastroenterology, 251 Airforce General Hospital of Athens; and the "Sismanoglio" General Hospital of Athens. Eligible control individuals were adults without symptoms of GERD, and without a history of esophageal or other gastrointestinal cancer, a known diagnosis of BE or reflux esophagitis. In all GERD cases, the diagnosis was endoscopically confirmed (according to the Los Angeles classification for GERD).[@b11-jnm-25-436] Patients who suffered symptoms such as heartburn, chest pain, regurgitation, or dyspepsia for several weeks per month or moderate to severe symptoms more than once per week for at least 3 months were recruited. All patients answered the GERD-Health Related Quality of Life Questionnaire (GERD-HRQL) translated into Greek, for estimating the typical symptoms of GERD.[@b12-jnm-25-436] Exclusion criteria were the presence of gastroenterological surgery, esophageal motility disorders, BE, benign gastric ulcer, duodenal ulcer, gastroduodenal malignancies, and those who were under anti-reflux medication. All participants provided written informed consent before entering into the study. The study was conducted in accordance with the Declaration of Helsinki and was approved by Hospital Ethics committee.

Genotyping
----------

Genomic DNA was extracted from whole peripheral blood using the Nucleospin Blood Kit (MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany) according to the manufacturer instructions. Allele specific polymerase chain reaction (PCR) method was used to identify both polymorphisms, rs11789015(A/G) and rs4965272(G/T), where 2 different PCR reactions are performed with one or the other allele specific primer. For the rs11789015 the primers used were a common forward 5′GGTCCTAAGAAGATGGCGTTTG′3, and a reverse for the G-allele: 5′-GATGGGGAAGCGTCTGAAAAC-3′ and one for the A-allele: 5′-GATGGGGAAGCGTCTGAAAAT-3′ which produced a 222-bp DNA fragment. For the rs4965272 polymorphism, allele-specific PCR was performed using the following sense primers: rs4965272G 5′-GAGTATATCTTTGTTGCTTCG-3′, rs4965272T allele 5′-GAGTATATCTTTGTTGCTTCG-3′ with the common reverse primer rs4965272R: 5′-ATTCACAGTGTTCCAGGTA-3′ which amplified a 229-bp DNA product.

Statistical Methods
-------------------

Genotype frequencies were compared with the χ^2^ test with Yate's correction using S-Plus (v.6.2 Insightful, Seattle, WA, USA). Odds ratios (OR) and 95% CI were obtained with GraphPad (version 300; GraphPad Software, San Diego, CA, USA). Hardy-Weinberg equilibrium was verified by calculating the expected frequencies and numbers and was tested separately in patients and controls using the goodness-of-fit χ^2^ test. The *P*-values are all 2-sided. *P*-values of \< 0.05 were considered significant.

Results
=======

Study Population and Demographics
---------------------------------

A total of 160 GERD patients, and 180 healthy controls were examined. The demographic characteristics of subjects are presented in [Table 1](#t1-jnm-25-436){ref-type="table"}. The study group included 83 males (51.87%) and 77 females (48.12%), with a mean age of 58.05 ± 24.10 years. The control group consisted of 92 males (51.11%) and 88 females (48.89%) healthy subjects, with a mean age of 61.70 ± 18.50. Gender, age, and smoking status are independent clinical-demographic factors. The mean body mass index in GERD patients was 27.82 ± 3.28. The most common symptom, presented in 91.25% of GERD patients was heartburn, followed by chest pain (41.25% of GERD patients). According to the endoscopic findings, as illustrated in [Table 1](#t1-jnm-25-436){ref-type="table"}, the GERD cases were graded as A, B, C or D of the classification. Furthermore, in 46.88% of the patients no visible lesions were found on endoscopy, despite the presence of troublesome reflux-associated symptoms. These patients were characterized as NERD. Hiatus hernia as noticed in [Table 1](#t1-jnm-25-436){ref-type="table"} was founded in 47.50% of the patients, mainly in male population.

Genotyping Data
---------------

The distribution and frequency of genotypes for cases and controls are shown in [Table 2](#t2-jnm-25-436){ref-type="table"}. There were no significant departures from the Hardy-Weinberg equilibrium for either polymorphism in any of the subject groups. Regarding the rs11789015 polymorphism, both AG and GG genotypes frequencies (*P* = 0.032 and *P* = 0.033 respectively), as well as the minor allele G (*P* = 0.007) were significantly increased in GERD patients compared to healthy controls, exhibiting an association with susceptibility to GERD development. The rs4965272 polymorphism GG genotype was found to be overrepresented in GERD patients compared to healthy controls (*P* = 0.035). On the other hand, it is interesting to note that TG genotype and the G allele did not reveal any statistical difference in frequency between the 2 groups (*P* = 0.540 and *P* = 0.068).

Discussion
==========

Several studies have suggested that genetic factors substantially explain the pathogenesis of GERD, its complications (BE and EAC) and the phenotypic variance of the severity of some symptoms.[@b13-jnm-25-436] We reported an association between polymorphism of *BARX1* (rs11789015) and polymorphism of *ADAMTS17* (rs4965272) with the presence of GERD, defined by endoscopic presence or absence of erosive esophagitis. The *BARX1* gene located at the 9q22 chromosome was suggested by Levine et al[@b7-jnm-25-436] as susceptible to the development of BE and EAC, whereas rs4965272 polymorphism was indicated by Bonfiglio et al[@b10-jnm-25-436] meta-analysis as a possible pathogenetic factor for GERD. The functions of the *BARX* genes mainly concern gene control and processes involved in myogenic differentiation. Early in gastrointestinal development, expression of the *BARX1* gene is limited to stomach mesenchyme. *BARX1* mainly regulates the expression of *sFRP1* and *sFRP2*, genes that reduce Wnt's (Wingless-related integration site) activity. These signals act on the endoderma to differentiate the stomach epithelium.[@b8-jnm-25-436],[@b14-jnm-25-436] Especially, the rs11789015 locus, which is located in intron 3 of the gene homeobox protein BarH-like 1b (BARX1) at the 9q22 chromosome, encodes a transcription factor important in esophageal differentiation.[@b15-jnm-25-436] It is found that dysregulation of this gene is susceptible to the development of BE and EAC, probably by reducing anatomical anti-reflux mechanisms.[@b7-jnm-25-436]--[@b9-jnm-25-436] In our study, patients carrying the heterozygous AG genotype or the homozygous GG genotype at the rs11789015 polymorphism of the *BARX1* gene demonstrated an increased odds (*P* = 0.030 each) of developing GERD. These findings are in accordance with the studies mentioned correlating the polymorphism with the onset of the complications of GERD.

Furthermore, we showed that carriers of the homozygous GG genotype of the *ADAMTS17* polymorphism (rs4965272) have 3.42-fold increased odds of GERD compared to those carrying the TT genotype, while the presence of G allele alone is not sufficient to increase the odds. The *ADAMTS17* gene codes for a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family, which comprises of 19 secreted proteases primarily associated with the extra-cellular matrix and is involved in a wide range of human biological processes with potential roles in arthritis, cancer, angiogenesis, atherosclerosis, central nervous system disorders, and fertility.[@b16-jnm-25-436],[@b17-jnm-25-436] ADAMTS17 is widely expressed in human tissues but the function of this protein has not been yet determined. Mutations in *ADAMTS17* have been identified as a cause of autosomal-recessive Weill--Marchesani syndrome.[@b18-jnm-25-436] This gene could be expressed at different levels in different cell types and give rise to different regulatory influences on microfibrils in the cell environment.[@b19-jnm-25-436] From a newly published meta-analysis of reflux genome-wide association, it is revealed that *ADAMTS17* and especially its SNP rs4465272, is strongly associated with the GERD pathogenesis.[@b10-jnm-25-436]

Acid regurgitation and heartburn were the cardinal symptoms among the GERD patients. Acid regurgitation was described in approximately 98.13% of the patients, mentioned mostly as a frequent symptom during the week, described as a sour taste in the mouth or as a sense of fluid moving up and down in the chest. Heartburn was described as a burning sensation under the sternum, differentiated with chest pain, the latter defined as angina or a pressure or squeezing pain behind the sternum. Furthermore, it is widely accepted that the incidence of reflux symptoms rises progressively with increasing body mass index. The latter was measured in both controls and GERD patients. A correlation between GERD and overweight patients was found, which is in accordance with previous studies.[@b13-jnm-25-436]

There are several limitations to this study. First, the study population is a small sample taken from 3 hospitals and do not necessarily represent the general population. Second, according to the demographic's characteristics, we could not reach conventional levels of statistical significance for gender or smoking status. Recent studies revealed a correlation between the female sex and the onset of GERD, with the female hormones (progesterone and estrogen) and the more frequent existence of hiatal hernia in women as potential risk factors.[@b20-jnm-25-436]--[@b22-jnm-25-436] Moreover, according to smoking, Zheng et al[@b23-jnm-25-436] concluded that a dose-dependent smoking was linked with the occurrence of GERD. Respectively, the latter could explain the absence of association between smoking and GERD in our study, since we did not measure the quantity of cigarettes, but only collected data whether the patients were current smokers or non-smokers. Third, dietary patterns, physical activity, additional medications affecting esophageal and gastric motility, and other environmental exposures were not accounted. Under these conditions, our results may be attenuated, and our associations may actually be stronger than reported.

In conclusion, this study provides evidence of a correlation between the objective presence of GERD and both the *BARX1* (rs11789015) and *ADAMTS17* (rs4965272) polymorphisms in a Greek population. The relationship with *BARX1* may be related to its role to the esophageal differentiation. The *ADAMTS17* association could be allied with its influence on microfibrils in the cell environment, as its specific role has not yet been determined. Further investigation in larger population groups and in different nationalities is needed to confirm these findings.
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###### 

Demographics and Clinical Characteristics of Patients

  Variables                  Controls        GERD            *P*-value (GERD vs controls)
  -------------------------- --------------- --------------- ------------------------------
  Sex                                                        0.888
   Male                      92 (51.11)      83 (51.87)      
   Female                    88 (48.89)      77 (48.12)      
  Age (yr)                   61.70 ± 18.50   58.05 ± 24.10   0.116
  Smoking status                                             0.079
   Never                     72 (40.00)      66 (41.25)      
   Ex-smoker                 76 (42.22)      53 (33.12)      
   Current                   32 (17.78)      41 (25.62)      
  BMI                        25.60 ± 4.30    27.82 ± 3.28    \< 0.001
  Heartburn                                                  \< 0.001
   Yes                                       146             
   No                                        14              
  Chest pain                                                 
   Yes                                       66              0.003
   No                                        94              
  Acid regurgitation                                         \-
   Never                                     3               
   Occasionally                              40              
   Sometimes                                 51              
   Frequently                                42              
   Always                                    24              
  Endoscopic findings                                        
   NERD                                                      
    Yes                                      75              0.314
    No                                       85              
   ERD (LA classification)                                   \-
    A                                        26              
    B                                        37              
    C                                        16              
    D                                        6               
   Hiatus hernia                             76              
    Male                                     52              0.011
    Female                                   24              

GERD, gastroesophageal reflux disease; BMI, body mass index; NERD, non-erosive reflux disease; LA, Los Angeles; ERD, erosive reflux disease.

Values are presented as n (%) or mean ± SD.

###### 

Frequency of rs11789015 and rs4965272 Genotypes and Risk of Gastroesophageal Reflux Disease

  Polymorphism       Controls (n = 180)   GERD (n = 160)   *P*-value; OR (95% CI)
  ------------------ -------------------- ---------------- ---------------------------
  rs11789015 (A/G)                                         
   AA                102                  68               1.000 \[reference\]
   AG                71                   78               0.032; 1.65 (1.06--2.57)
   GG                7                    14               0.033; 3 (1.15--7.82)
  A allele           275                  214              1.000 \[reference\]
  G allele           85                   106              0.007; 1.603 (1.14--2.24)
  rs4965272 (T/G)                                          
   TT                128                  103              1.000 \[reference\]
   TG                48                   46               0.540; 1.91 (0.74--1.93)
   GG                4                    11               0.035; 3.42 (1.06--11.05)
   T allele          304                  252              1.000 \[reference\]
   G allele          56                   68               0.068; 1.46 (0.99--2.16)

GERD, gastroesophageal reflux disease.
